NeuroVive Pharmaceutical AB Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | NeuroVive Pharmaceutical AB

NeuroVive Pharmaceutical AB | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Andra AP Fonden

125,463

0.14%

125,463

12/31/2016

SEB Sverige Indexfond

54,708

0.06%

12/31/2017

26,000

0.03%

09/11/2018

Catella Sverige Index

5,343

0.01%

08/31/2018

Handelsbanken Sverigefond Index

-319,309

08/31/2018

Handelsbanken Sverige Criteria

-99,794

08/31/2018

View Profile

Address	Medicon Village Lund SN 223 81 Sweden
Employees	-
Website	http://www.neurovive.com
Updated	07/08/2019
NeuroVive Pharmaceutical AB engages in the research and development of pharmaceuticals that protect mitochondria from death post acute traumatic injury. The company was founded by Eskil Elmer on February 1, 2000 and is headquartered in Lund, Sweden. .